» Articles » PMID: 28992071

Prenatal Screening for and Prevalence of Hepatitis B Surface Antigen in Pregnant Women and Prevention of Transmission to Infants Born to Infected Mothers-Guam, 2014

Overview
Date 2017 Oct 10
PMID 28992071
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Perinatal transmission is the major mode of hepatitis B virus (HBV) transmission and drives HBV endemicity in the US territory of Guam. We assessed correlates of prenatal hepatitis B surface antigen (HBsAg) screening and HBsAg positivity among pregnant women and evaluated the care of infants of HBsAg-positive women.

Methods: Demographic and clinical data were abstracted from the maternal medical records of 966 randomly selected live infants born in 2014. Frequencies were calculated, and prevalence ratios (PRs) and 95% confidence intervals (CIs) were estimated using Poisson regression.

Results: Among the mothers of the 966 infants, 78.2% were Pacific Islanders, 56.9% were >25 years old (born before universal infant hepatitis B vaccination in Guam), 89.0% received prenatal care (PNC), 96.7% underwent prenatal HBsAg screening, and 2.0% were HBsAg positive. Approximately 15% of the women who did not have PNC were not screened for HBsAg. Receipt of PNC was associated with HBsAg screening (adjusted PR, 1.13 [95% CI, 1.04-1.23]), and HBsAg positivity was associated with a maternal age of >25 years (adjusted PR, 6.80 [95% CI, 1.32-35.08]). All 18 infants of the HBsAg-positive mothers received hepatitis B vaccine, and 17 (94.4%) received hepatitis B immunoglobulin.

Conclusion: Although the prenatal HBsAg screening prevalence in this sample was high, the maternal HBsAg prevalence among women in this sample was more than 14 times and 2 times the prevalence among US-born Pacific Islander/Asian women and all women in the continental United States, respectively. Improving access to PNC, ensuring that all pregnant women in Guam (especially those born before universal hepatitis B vaccination) are screened for HBsAg, and adopting postexposure prophylaxis for infants of HBsAg-positive mothers as standard clinical practice are important for preventing perinatal HBV transmission and reducing HBV endemicity.

Citing Articles

Progress towards triple elimination of mother-to-child transmission of HIV, hepatitis B and syphilis in Pacific Island Countries and Territories: a systematic review.

Bell L, van Gemert C, Allard N, Brink A, Chan P, Cowie B Lancet Reg Health West Pac. 2023; 35:100740.

PMID: 37424691 PMC: 10326693. DOI: 10.1016/j.lanwpc.2023.100740.


Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations - United States, 2023.

Conners E, Panagiotakopoulos L, Hofmeister M, Spradling P, Hagan L, Harris A MMWR Recomm Rep. 2023; 72(1):1-25.

PMID: 36893044 PMC: 9997714. DOI: 10.15585/mmwr.rr7201a1.


Sero-prevalence and associated factors of hepatitis B virus among pregnant women in Hawassa city public hospitals, Southern Ethiopia: Cross-sectional study design.

Kassaw B, Abera N, Legesse T, Workineh A, Ambaw G SAGE Open Med. 2022; 10:20503121221140778.

PMID: 36505974 PMC: 9730001. DOI: 10.1177/20503121221140778.


Pregnancy health and perinatal outcomes among Pacific Islander women in the United States and US Affiliated Pacific Islands: Protocol for a scoping review.

Suss R, Mahoney M, Arslanian K, Nyhan K, Hawley N PLoS One. 2022; 17(1):e0262010.

PMID: 35041684 PMC: 8765672. DOI: 10.1371/journal.pone.0262010.


Efficacy and safety of telbivudine treatment for the prevention of HBV perinatal transmission.

Ren C, Wang L, Sun W, Ma L, Dong Z, Hao A Medicine (Baltimore). 2020; 99(24):e20583.

PMID: 32541488 PMC: 7302680. DOI: 10.1097/MD.0000000000020583.

References
1.
Schweitzer A, Horn J, Mikolajczyk R, Krause G, Ott J . Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015; 386(10003):1546-55. DOI: 10.1016/S0140-6736(15)61412-X. View

2.
Smith E, Jacques-Carroll L, Walker T, Sirotkin B, Murphy T . The national Perinatal Hepatitis B Prevention Program, 1994-2008. Pediatrics. 2012; 129(4):609-16. DOI: 10.1542/peds.2011-2866. View

3.
Roberts H, Kruszon-Moran D, Ly K, Hughes E, Iqbal K, Jiles R . Prevalence of chronic hepatitis B virus (HBV) infection in U.S. households: National Health and Nutrition Examination Survey (NHANES), 1988-2012. Hepatology. 2015; 63(2):388-97. DOI: 10.1002/hep.28109. View

4.
Terrault N, Bzowej N, Chang K, Hwang J, Jonas M, Murad M . AASLD guidelines for treatment of chronic hepatitis B. Hepatology. 2015; 63(1):261-83. PMC: 5987259. DOI: 10.1002/hep.28156. View

5.
Edmunds W, Medley G, Nokes D, Hall A, Whittle H . The influence of age on the development of the hepatitis B carrier state. Proc Biol Sci. 1993; 253(1337):197-201. DOI: 10.1098/rspb.1993.0102. View